Results to your Biomarker

Exposure to
Analytical Technique
Propylene glycol (PG)
Propylene glycol
Urine, Plasma, Serum, Saliva, PBS, Aerosol, ETS, e-liquids

Matching services



Human biomonitoring (HBM) is the determination of pollutants or their metabolites in biological material (blood, urine, saliva, etc.). With the help of HBM, the exposure to environmental chemicals can be assessed to identify vulnerable populations or regional differences.

Tobacco Harm Reduction

Tobacco harm reduction is a public health strategy to lower the health risks to individuals and wider society associated with using tobacco products. Biomarkers specific for the exposure to tobacco and smoke are key endpoints for evaluating new emerging nicotine products with a potentially reduced risk.

Scientific Contribution

March 2019

Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled Ingredients

Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
Conference contribution
October 2017

Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–results

CORESTA SSPT 2017, Kitzbühel, Austria
October 2021

1,2-Propylene Glycol: A Biomarker of Exposure Specific to e-Cigarette Consumption

Separations, 8, 180, doi: 10.3390/separations8100180
Conference contribution
March 2022

Propylene glycol: A Biomarker of Exposure specific to E-Cigarette Consumption

SRNT 2022, Baltimore (Hybrid), USA
Conference contribution
September 2022

Propylene glycol as a specific biomarker for e-cigarette use Showcase of a novel Orbitrap-MS-based exposomics approach

ISES 2022, Lisbon